Mersana Therapeutics, Inc. Annual Income Tax Expense (Benefit) in USD from 2015 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Mersana Therapeutics, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2015 to 2023.
  • Mersana Therapeutics, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $418K.
  • Mersana Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2023 was $0.000.
  • Mersana Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2022 was $0.000.
  • Mersana Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2021 was $0.000.
Income Tax Expense (Benefit), Annual (USD)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.